The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2006
Filed:
Nov. 18, 2004
Robert Steven Kania, San Diego, CA (US);
Steven Lee Bender, Oceanside, CA (US);
Allen J. Borchardt, San Diego, CA (US);
Stephan James Cripps, San Diego, CA (US);
YE Hua, Oceanside, CA (US);
Michael David Johnson, San Diego, CA (US);
Theodore Otto Johnson, Jr., San Diego, CA (US);
Hiep the Luu, San Diego, CA (US);
Cynthia Louise Palmer, La Mesa, CA (US);
Siegfried Heinz Reich, Solana Beach, CA (US);
Anna Maria Tempczyk-russell, Ramona, CA (US);
Min Teng, San Diego, CA (US);
Christine Thomas, West Borough, ME (US);
Michael David Varney, Solana Beach, CA (US);
Michael Brennan Wallace, San Diego, CA (US);
Michael Raymond Collins, San Diego, CA (US);
Robert Steven Kania, San Diego, CA (US);
Steven Lee Bender, Oceanside, CA (US);
Allen J. Borchardt, San Diego, CA (US);
Stephan James Cripps, San Diego, CA (US);
Ye Hua, Oceanside, CA (US);
Michael David Johnson, San Diego, CA (US);
Theodore Otto Johnson, Jr., San Diego, CA (US);
Hiep The Luu, San Diego, CA (US);
Cynthia Louise Palmer, La Mesa, CA (US);
Siegfried Heinz Reich, Solana Beach, CA (US);
Anna Maria Tempczyk-Russell, Ramona, CA (US);
Min Teng, San Diego, CA (US);
Christine Thomas, West Borough, ME (US);
Michael David Varney, Solana Beach, CA (US);
Michael Brennan Wallace, San Diego, CA (US);
Michael Raymond Collins, San Diego, CA (US);
Agouron Pharmaceuticals, Inc., La Jolla, CA (US);
Abstract
Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.